1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
MLSC Novel Therapeutics Delivery Capital Grant Program is sponsored by Massachusetts Life Sciences Center (MLSC). This grant fosters the development of novel technologies and techniques for the delivery of existing or innovative therapies by supporting equipment and other capital expenses at not-for-profit partners. Materials science plays a crucial role in developing novel drug delivery systems.
Get alerted about grants like this
Save a search for “Massachusetts Life Sciences Center (MLSC)” or related topics and get emailed when new opportunities appear.
Search similar grants →According to the current listing, eligibility includes: Not-for-profit partners (including universities) are eligible. Confirm the full requirements in the official notice before applying.
MLSC Novel Therapeutics Delivery Capital Grant Program is funded by Massachusetts Life Sciences Center (MLSC). Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
Past winners and funding trends for this program
Awards slashed by half, life sciences applicants rejected at 95%, and the White House steering which fields get funded. How the GRFP went from funding the person to funding the priority.
Read articleCummings Foundation's 2026 grant round opens July 15 and closes September 17. The $30M will be split across 150 Massachusetts nonprofits as 3-year and 10-year multi-year grants — a structure designed around operating support, not project capital, and selected largely by community volunteers rather than program officers.
Read articleSchmidt Sciences' 2026 Science of Trustworthy AI RFP closes May 17 with two funding tiers — up to $1M (Tier 1) and $1–5M+ (Tier 2) over 1–3 years, with a 10% indirect cost cap. The three research aims target misalignment under distribution shift, predictive-validity evaluations, and oversight of superhuman systems. Here is why the structure favors team-based proposals.
Read article